Zobrazeno 1 - 10
of 301
pro vyhledávání: '"George Wilding"'
Autor:
J. Jack Lee, George Wilding, Aman Buzdar, James C. Yao, David S. Hong, Suzanne E. Davis, Jun Weng, Mellanie Price, Steven I. Sherman, Chad Tang
Figure legend for supplemental figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a104c8b521082b6ddebe2b9f1263e10a
https://doi.org/10.1158/1078-0432.22464287.v1
https://doi.org/10.1158/1078-0432.22464287.v1
Autor:
Robert S. DiPaola, George Wilding, Janice J. Dutcher, Michael B. Atkins, Christopher G. Wood, Lori Wood, Michael Jewett, Christopher J. Kane, Robert G. Uzzo, Keith T. Flaherty, Bonnie Ky, Judith Manola, Naomi B. Haas
Purpose: Sunitinib and sorafenib are used widely in the treatment of renal cell carcinoma (RCC). These agents are associated with a significant incidence of cardiovascular (CV) dysfunction and left ventricular ejection fraction (LVEF) declines, obser
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12fa09c296f419eebfab4d0db0d4e58a
https://doi.org/10.1158/1078-0432.c.6523328
https://doi.org/10.1158/1078-0432.c.6523328
Autor:
Brian M. Olson, George Wilding, Glenn Liu, Mary Jane Staab, Isabel Pohlkamp, Eric Bradley, Laura E. Johnson, Jens C. Eickhoff, Jordan T. Becker, Douglas G. McNeel
PDF file - 26KB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::406f899319be29bdb0fa87cd2b86c297
https://doi.org/10.1158/1078-0432.22454918
https://doi.org/10.1158/1078-0432.22454918
Autor:
Robert S. DiPaola, George Wilding, Janice J. Dutcher, Michael B. Atkins, Christopher G. Wood, Lori Wood, Michael Jewett, Christopher J. Kane, Robert G. Uzzo, Keith T. Flaherty, Bonnie Ky, Judith Manola, Naomi B. Haas
Supplementary Figure: Consort diagram of patients participating in cardiac sub study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e36a0b8b6222573111696e2deb5fe2b
https://doi.org/10.1158/1078-0432.22456487.v1
https://doi.org/10.1158/1078-0432.22456487.v1
Autor:
J. Jack Lee, George Wilding, Aman Buzdar, James C. Yao, David S. Hong, Suzanne E. Davis, Jun Weng, Mellanie Price, Steven I. Sherman, Chad Tang
Trial Inclusion Diagram
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0630d5594a23560ef3ffcefbd35cf825
https://doi.org/10.1158/1078-0432.22464293.v1
https://doi.org/10.1158/1078-0432.22464293.v1
Autor:
J. Jack Lee, George Wilding, Aman Buzdar, James C. Yao, David S. Hong, Suzanne E. Davis, Jun Weng, Mellanie Price, Steven I. Sherman, Chad Tang
Slow accruing national cooperative group trials with respect to submission year
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f37fffcae8ff3acda723ab2609e8fca
https://doi.org/10.1158/1078-0432.22464290
https://doi.org/10.1158/1078-0432.22464290
Autor:
J. Jack Lee, George Wilding, Aman Buzdar, James C. Yao, David S. Hong, Suzanne E. Davis, Jun Weng, Mellanie Price, Steven I. Sherman, Chad Tang
Purpose: Slow-accruing clinical trials delay the translation of basic biomedical research, contribute to increasing health care costs, and may prohibit trials from reaching their original goals.Experimental Design: We analyzed a prospectively maintai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a491c5605c974de630bcf195b3fdc51
https://doi.org/10.1158/1078-0432.c.6525668.v1
https://doi.org/10.1158/1078-0432.c.6525668.v1
Autor:
Brian M. Olson, George Wilding, Glenn Liu, Mary Jane Staab, Isabel Pohlkamp, Eric Bradley, Laura E. Johnson, Jens C. Eickhoff, Jordan T. Becker, Douglas G. McNeel
PDF file - 729KB, Supplementary Table 1: Adverse events. Supplementary Figure 1: Patient allocation. Supplementary Figure 2: DNA immunization elicits PAP-specific cellular immune responses. Supplementary Figure 3: Immune responses to PSA and tetanus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dba0c060ade5ef364baa3e39b4e27d4
https://doi.org/10.1158/1078-0432.22454915
https://doi.org/10.1158/1078-0432.22454915
Autor:
Brian M. Olson, George Wilding, Glenn Liu, Mary Jane Staab, Isabel Pohlkamp, Eric Bradley, Laura E. Johnson, Jens C. Eickhoff, Jordan T. Becker, Douglas G. McNeel
Purpose: We have previously reported that a DNA vaccine encoding prostatic acid phosphatase (PAP) could elicit PAP-specific T cells in patients with early recurrent prostate cancer. In the current pilot trial, we sought to evaluate whether prolonged
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02934f1a197e2fa5a22b5b00680ec781
https://doi.org/10.1158/1078-0432.c.6522872
https://doi.org/10.1158/1078-0432.c.6522872
Autor:
Robert S. DiPaola, George Wilding, Janice J. Dutcher, Michael B. Atkins, Christopher G. Wood, Lori Wood, Michael Jewett, Christopher J. Kane, Robert G. Uzzo, Keith T. Flaherty, Bonnie Ky, Judith Manola, Naomi B. Haas
Supplementary Tables 1-5, Figures 1-3. Supplemental Table 1: Events per person-year of follow-up Supplemental Table 2: Event rates among patients randomized to sorafenib or sunitinib who started at reduced vs. full dose Supplemental Table 3a. Event r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48928bf28fff5fc4f473444725ebe2f6
https://doi.org/10.1158/1078-0432.22456484.v1
https://doi.org/10.1158/1078-0432.22456484.v1